We are live on ! Find out more
ACHV icon

Achieve Life Sciences
ACHV

29 hedge funds and large institutions have $14.9M invested in Achieve Life Sciences in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

695% more call options, than puts

Call options by funds: $167K | Put options by funds: $21K

1.45% more ownership

Funds ownership: 18.87% → 20.31% (+1.4%)

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

1% less capital invested

Capital invested by funds: $15.2M → $14.9M (-$220K)

9% less funds holding

Funds holding: 32 → 29 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
29
Holders Change
-3
Holders Change %
-9.38%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
9
Reduced
9
Closed
7
Calls
$167K
Puts
$21K
Net Calls
+$146K
Net Calls Change
+$146K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$604K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$589K
3
SC
Shay Capital
New York
+$200K
4
Citadel Advisors
Citadel Advisors
Florida
+$151K
5
PVI
Pura Vida Investments
New York
+$128K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$439K
2
GCP
GSA Capital Partners
United Kingdom
-$327K
3
Two Sigma Investments
Two Sigma Investments
New York
-$158K
4
ASN
Advisory Services Network
Georgia
-$111K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$93K
Name Holding Trade Value Shares
Change 		Change in
Stake
SC
1
Shay Capital
New York
$3.16M +$200K +25,427 +7%
Vanguard Group
2
Vanguard Group
Pennsylvania
$2.69M +$604K +76,918 +29%
PCM
3
Perkins Capital Management
Minnesota
$1.36M +$39.3K +5,000 +3%
6CM
4
683 Capital Management
New York
$973K – – –
ACM
5
Altium Capital Management
New York
$949K – – –
CC
6
Clearline Capital
New York
$949K – – –
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$780K +$589K +74,965 +296%
Geode Capital Management
8
Geode Capital Management
Massachusetts
$665K – – –
LPL Financial
9
LPL Financial
California
$536K -$24K -3,050 -4%
LFCM
10
Long Focus Capital Management
Puerto Rico
$467K +$471K +60,000 New
Morgan Stanley
11
Morgan Stanley
New York
$428K -$439K -55,863 -50%
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$322K +$74.7K +9,500 +30%
Franklin Resources
13
Franklin Resources
California
$264K -$652 -83 -0.2%
OC
14
Oppenheimer & Co
New York
$193K -$1.57K -200 -0.8%
Renaissance Technologies
15
Renaissance Technologies
New York
$185K +$9.43K +1,200 +5%
Citadel Advisors
16
Citadel Advisors
Florida
$149K +$151K +19,207 New
Two Sigma Advisers
17
Two Sigma Advisers
New York
$134K -$91.2K -11,600 -40%
Northern Trust
18
Northern Trust
Illinois
$132K -$2.34K -298 -2%
PVI
19
Pura Vida Investments
New York
$127K +$128K +16,325 New
BlackRock
20
BlackRock
New York
$119K +$98K +12,470 +456%
State Street
21
State Street
Massachusetts
$115K – – –
TPA
22
Trivium Point Advisory
Connecticut
$91K -$393 -50 -0.4%
OQS
23
Occudo Quantitative Strategies
Florida
$86K -$15.5K -1,967 -15%
Wells Fargo
24
Wells Fargo
California
$43K +$7.88K +1,003 +22%
Osaic Holdings
25
Osaic Holdings
Arizona
$13K +$715 +91 +6%
1
2

ACHV Hedge Fund Activity: Q4 2021 in Review

29 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q4 2021, worth a combined $14.9M — down 1.5% from $15.2M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of ACHV and 4 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 9 added.

The largest buyer was Vanguard Group, adding an estimated $604K. The largest seller was Morgan Stanley, cutting an estimated $439K.

  • 29 institutional investors held Achieve Life Sciences (ACHV) as of Q4 2021, down from 32 in Q3 2021.
  • Funds reported $14.9M of Achieve Life Sciences stock for Q4 2021, down 1.5% quarter-over-quarter.
  • 4 funds opened new Achieve Life Sciences positions in Q4 2021 and 7 closed out, a net change of -3 holders.
  • The largest Achieve Life Sciences buyer in Q4 2021 was Vanguard Group, an estimated $604K added.
  • The largest Achieve Life Sciences seller in Q4 2021 was Morgan Stanley, an estimated $439K sold.

Based on aggregated 13F filings for Q4 2021.